Official websites use .gov
Secure .gov websites use HTTPS
Some manufacturers reported inaccurate drug product data to CMS
Some manufacturers reported inaccurate drug product data to CMS
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Data snapshot
- Contributor(s):
- United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body.
- Publication:
- [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Data Accuracy
Drug Industry -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services - Genre(s):
- Technical Report
- Abstract:
- What OIG Did. The Office of Inspector General (OIG) conducted a review of the accuracy of average sales price (ASP) product data and average manufacturer price (AMP) product data for 1,345 National Drug Codes (NDCs) associated with drugs covered by Medicare Part B for 2018. (Drugs covered by Part B are generally those that are injected or infused in physicians’ offices or hospital outpatient settings.) We identified these out of a total of 3,527 NDCs associated with Part B-covered drugs for which manufacturers submitted both ASP data and AMP data for that year. For Part B-covered drugs, the Centers for Medicare & Medicaid Services (CMS) uses manufacturer-reported ASP pricing and product data to determine reimbursement amounts. For Medicaid-covered drugs, CMS uses manufacturer-reported AMP pricing and product data to calculate the statutorily required Medicaid rebates that reduce the net cost of those drugs. To assess the accuracy of ASP and AMP product data, we compared (1) the package size and package quantity that manufacturers reported as part of the ASP product data against the drugs’ labels, drug package inserts, and drug manufacturers’ websites (hereinafter referred to as “publicly available sources”); (2) the unit type and units per package size that manufacturers reported as part of the AMP product data against the information listed in publicly available sources; and (3) the package size that manufacturers reported as part of the ASP product data against the unit type reported with the AMP product data.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (6 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918282678906676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918282678906676